Breaking News Headlines Today

News from Interventional News

See all of Interventional News news coverage in one place. Discover how Interventional News’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve discovered 53 headlines written by Interventional News during the past 3 months.

The Ground News media bias check for Interventional News is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Interventional News’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Interventional News

Where is Interventional News located?Interventional News's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Interventional News News

Technology · United Kingdom

MHRA Announces Proposals to Improve Access to World’s Best Medical Devices for Patients and to Boost Economic Growth in Britain’s Med Tech Sector

The MHRA has now published the government’s response to its public consultation on future routes to market for medical devices - designed to modernise regulation See the Story

New York City · New York

Philips receives FDA 510(k) clearance for image-guided navigation system for prostate cancer - Interventional News

Philips UroNav Philips has announced the FDA 510(k) clearance of the latest Philips UroNav system. In a recent press release made by the company, it states that the system includes a new advanced annotation workflow that supports clinicians during focal therapy procedures, helping deliver more precise, minimally invasive care. “We’re entering a new era of precision prostate cancer care. Philips’ integrated focal therapy platform unifies imaging,…Read Article

United States · United States

Breakthrough Prostate Cancer Treatment Preserves Sexual Function in 84% of Patients, New Study Reveals

European Urology publishes PRESERVE trial results showing NanoKnife System's effectiveness in prostate cancer treatment with quality-of-life preservation. See full data.See the Story

EMBO-02 Study Indicates Rapid cSDH Resorption and Pain-Free Treatments with NeoCast Liquid Embolic Agent

Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic subdural haematoma (cSDH) via middle meningeal artery embolisation (MMAe). Research presented across multiple sessions at the Society of NeuroInterventional Surgery (SNIS) annual meeting (14–18 July, Nashville, USA) showed that all patients met prima…Arsenal FC · Western Australia See the Story

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).The post First subject enrolled in trial of Medtronic’s liquid embolic system appeared first on Medical Device Network.Albany, New York · Albany See the Story

Varian launches microwave ablation system for soft tissue tumours in Europe

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.The post Varian launches microwave ablation system for soft tissue tumours in Europe appeared first on Medical Device Network.See the Story

FastWave Medical secures eighth US patent for IVL portfolio - Interventional News

FastWave Medical IVL system FastWave Medical has secured its eighth US patent for its electric intravascular lithotripsy (E-IVL) platform, Artero, reflecting the company’s continued innovation in developing next-generation solutions for peripheral arterial disease (PAD) treatment, the company reports in a press release. “IVL has become one of my frontline tools for treating peripheral arterial disease—it’s one of the most exciting breakthroughs…Innovation · Miami Read Article

Geneticure’s test obtains US patent to predict renal denervation response

The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.The post Geneticure’s test obtains US patent to predict renal denervation response appeared first on Medical Device Network.Cleveland, Ohio · Cleveland See the Story

Medtronic Stock Gains as CMS Proposes Coverage for Renal Denervation

Coverage: 2 sources

Palo Alto, CA, July 10, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for the Centers for Medicare and Medicaid Services’ (CMS) proposed National…Medicare · United States See the Story

Mendaera receives FDA 510(k) clearance for robotic system for ultrasound-guided needle placement - Interventional News

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system designed to improve the precision of ultrasound-guided needle placement. According to the company in a recent press release, the system combines real-time imaging with a handheld robotic control to assist clinicians in performing a wide range of minimally invasive procedures and settings. Its features include robotic needle p…United States · United States Read Article

Why Is Merit Medical Stock Trading Higher On Tuesday? - Merit Medical Systems (NASDAQ:MMSI)

60% Center coverage: 5 sources

Merit Medical Systems Inc. (NASDAQ:MMSI) announced a leadership transition on Monday, naming Martha Aronson as its next President and CEO, effective October 3, 2025. Current CEO Fred Lampropoulos, who founded the company in 1987, will continue to serve as Chairman of the Board following the transition. The Utah-based medical technology company also provided early revenue estimates for the second quarter, projecting between $380 million and $384 …Health Care See the Story

News from Interventional News

News from Interventional News

Information about Interventional News

Media Bias Ratings

Factuality

Ownership

Top Interventional News News

MHRA Announces Proposals to Improve Access to World’s Best Medical Devices for Patients and to Boost Economic Growth in Britain’s Med Tech Sector

Philips receives FDA 510(k) clearance for image-guided navigation system for prostate cancer - Interventional News

Breakthrough Prostate Cancer Treatment Preserves Sexual Function in 84% of Patients, New Study Reveals

EMBO-02 Study Indicates Rapid cSDH Resorption and Pain-Free Treatments with NeoCast Liquid Embolic Agent

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Varian launches microwave ablation system for soft tissue tumours in Europe

FastWave Medical secures eighth US patent for IVL portfolio - Interventional News

Geneticure’s test obtains US patent to predict renal denervation response

Medtronic Stock Gains as CMS Proposes Coverage for Renal Denervation

Mendaera receives FDA 510(k) clearance for robotic system for ultrasound-guided needle placement - Interventional News

Why Is Merit Medical Stock Trading Higher On Tuesday? - Merit Medical Systems (NASDAQ:MMSI)

Similar News Topics

Topics Most Covered by Interventional News

Sources Covering Similar Topics

Breaking News Topics Related to Interventional News

Information about Interventional News

Media Bias Ratings

Factuality

Ownership

EMBO-02 Study Indicates Rapid cSDH Resorption and Pain-Free Treatments with NeoCast Liquid Embolic Agent

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Varian launches microwave ablation system for soft tissue tumours in Europe

FastWave Medical secures eighth US patent for IVL portfolio - Interventional News

Geneticure’s test obtains US patent to predict renal denervation response

Medtronic Stock Gains as CMS Proposes Coverage for Renal Denervation

Mendaera receives FDA 510(k) clearance for robotic system for ultrasound-guided needle placement - Interventional News

Why Is Merit Medical Stock Trading Higher On Tuesday? - Merit Medical Systems (NASDAQ:MMSI)